Chinook Therapeutics

We officially combined with Novartis to further strengthen our scientific capabilities and treatments for patients with rare kidney diseases. For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics See our community guidelines: https://go.novartis.social/3Slt0Up